Arlington VA 肺癌临床试验
41项针对 肺癌的研究正在 Arlington及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Kaiser Permanente Tysons Corner Medical Center, McLean · 距离 5 英里
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
招募中2 期
- Virginia Cancer Specialists (VCS) ( Site 0408), Fairfax · 距离 11 英里
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
招募中3 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
招募中3 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Study of PHN-012 in Patients With Advanced Solid Tumors
招募中1 期
- PHN-012-001 Site, Fairfax · 距离 11 英里
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
招募中1 期
- Inova Schar Cancer Infusion Pharmacy, Fairfax · 距离 11 英里
- Inova Schar Cancer, Fairfax · 距离 11 英里
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
招募中2 期
- Research Site, Fairfax · 距离 11 英里
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
招募中2/3 期
- Virginia Cancer Specialists - Arlington, Arlington
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
招募中1/2 期
- Next Oncology Virginia Cancer Specialist, Fairfax · 距离 11 英里
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
招募中1 期
- NEXT - Virginia, Fairfax · 距离 11 英里
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
招募中3 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
招募中1/2 期
- NEXT Virginia, Fairfax · 距离 11 英里
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- USO - Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
招募中1 期
- USO-Virginia Cancer Specialists, PC, Fairfax · 距离 11 英里
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
招募中1/2 期
- Avenzo Therapeutics Recruiting Site, Fairfax · 距离 11 英里
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
招募中1 期
- NEXT Oncology, Fairfax · 距离 11 英里
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中欢迎健康志愿者
- Inova Schar Cancer Institute, Fairfax · 距离 11 英里
- Inova Fair Oaks Hospital, Fairfax · 距离 11 英里
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
招募中3 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
招募中3 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
招募中3 期
- Inova Schar Cancer Institute, Fairfax · 距离 11 英里
- Inova Fair Oaks Hospital, Fairfax · 距离 11 英里
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
招募中1/2 期
- NEXT Virginia, Fairfax · 距离 11 英里
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
招募中1/2 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
招募中1 期
- Research Site, Fairfax · 距离 11 英里
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Kaiser Permanente Tysons Corner Medical Center, McLean · 距离 5 英里
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
招募中1 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
招募中1/2 期
- NEXT Virginia, Fairfax · 距离 11 英里
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
招募中1/2 期
- Next Oncology Virginia, Fairfax · 距离 11 英里
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
招募中1/2 期
- NEXT Oncology, Fairfax · 距离 11 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Kaiser Permanente Tysons Corner Medical Center, McLean · 距离 5 英里
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Kaiser Permanente Tysons Corner Medical Center, McLean · 距离 5 英里
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
招募中2 期
- Inova Fairfax Hospital, Fairfax · 距离 11 英里
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
招募中1/2 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
其他城市的 肺癌试验
- Houston, TX78 项研究
- Boston, MA62 项研究
- New York City, NY60 项研究
- Los Angeles, CA45 项研究
- Washington, DC41 项研究
- Chicago, IL41 项研究
- Nashville, TN40 项研究
- Baltimore, MD40 项研究
- St. Louis, MO39 项研究
- Columbus, OH37 项研究
- Philadelphia, PA36 项研究
- Seattle, WA33 项研究
Arlington的其他研究
- 非小细胞肺癌104 项研究
- 转移性癌症53 项研究
- 结直肠癌52 项研究
- 癌症（所有类型）48 项研究
- 乳腺癌46 项研究
- 卵巢癌46 项研究
- 子宫内膜癌39 项研究
- 胰腺癌33 项研究
- 头颈鳞状细胞癌26 项研究
- 小细胞肺癌23 项研究
- 三阴性乳腺癌20 项研究
- 胃癌20 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。